Suchergebnisse - (Person:"Wang, Xinning")

PubPharm (180)

61

Sirtuin 4 Inhibits Prostate Cancer Progression and Metastasis by Modulating p21 Nuclear Translocation and Glutamate Dehydrogenase 1 ADP-Ribosylation

enthalten in: Journal of oncology | 2022

von Mao, L. | Hong, X. | Xu, L. | +6

62

Effects of Surgery Combined with Different Chemotherapy on Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 in Children with Neuroblastoma

enthalten in: Journal of oncology | 2022

von Qi, Z. | Wang, X. | Yin, L. | +3

63

Capture Hi-C reveals the influence on dynamic three-dimensional chromosome organization perturbed by genetic variation or vanillin stress in Saccharomyces cerevisiae

enthalten in: Frontiers in microbiology | 2022

von Wang, X. | Yang, B. | Zhao, W. | +4

64

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer

enthalten in: Theranostics | 2022

von Wang, X. | Sun, R. | Wang, J. | +8

65

Administration of adipose stromal vascular fraction attenuates acute rejection in donation after circulatory death rat renal transplantation

enthalten in: International Journal of Urology | 2022

von Wang, X. | Zhou, C. | Liu, J. | +5

66

Development of a novel castration‐resistant orthotopic prostate cancer model in New Zealand White rabbit

enthalten in: The Prostate | 2022

von Wang, Y. | Abenojar, E. | Wang, J. | +10

67

Values of serum CA125, NSE and 24-hour urine VMA in diagnosis and prediction of treatment of paediatric neuroblastoma

enthalten in: International journal of clinical practice | 2021

von Li, J. | Liu, X. | Chen, M. | +2

68

PSMA targeted conjugate compounds and uses thereof

enthalten in: Europäisches Patentamt | 2021

von BASILION JAMES P | WANG XINNING | WALKER NATALIE

69

CXCR4 blockade reduces the severity of murine heart allograft rejection by plasmacytoid dendritic cell-mediated immune regulation

enthalten in: Scientific reports | 2021

von Fu, J. | Lehmann, C. | Wang, X. | +13

70

Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent

enthalten in: Journal of the American Chemical Society | 2021

von Li, H. | Luo, D. | Yuan, C. | +4